 
       
      | Bieżący numer
			Archiwum
		
				Filmy
				Artykuły w druku
				O czasopiśmie
				Suplementy
					Rada naukowa
				Recenzenci
				Bazy indeksacyjne
		
			
					Prenumerata
				Kontakt
				Zasady publikacji prac
	             Opłaty publikacyjne
     			Standardy etyczne i procedury Panel Redakcyjny Zgłaszanie i recenzowanie prac online | 
		2/2024
	 vol. 126 streszczenie artykułu: Artykuł przeglądowy Macular abnormalities in retinitis pigmentosa. Management and treatment
	
	             Magdalena  Durajczyk
	         1 , 
	             Katarzyna  Seredyńska
	         1 , 
	             Wojciech  Lubiński
	         1 
 KLINIKA OCZNA 2024, 126, 2: 59-64 Data publikacji online: 2024/05/22 
	Pełna treść artykułu
	
	
	
	Pobierz cytowanie
 ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA APA Chicago Harvard MLA Vancouver Aim To review the current state of knowledge on macular in retinitis pigmentosa, current treatment methods and management. Material and methods Analysis of literature available on PubMed. Presentation of own treatment results. Results Macular lesions occur in 11.5% to 59.7% of patients with pigmentary degeneration. The most commonly observed macular abnormalities include cystoid macular edema, epiretinal membranes, vitreomacular traction syndrome, and full-thickness macular holes. In conservative treatment, topical carbonic anhydrase inhibitors and steroids are the most effective. The best surgical treatment outcomes have been obtained for macular holes. Conservative and surgical treatment outcomes vary and depend on the stage of retinitis pigmentosa. Conclusions Macular abnormalities are often observed in patients with retinitis pigmentosa. arbonic anhydrase blockers and steroids can be effective in treating cystoid macular edema. Surgical treatment can improve macular morphology but improvement in visual function is limited due to long-term retinal dysfunction and progression of the underlying disease. |